| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/31/2002 | US20020013956 Meiotic recombination in vivo of partially homologous dna sequences |
| 01/31/2002 | US20020013955 Production of recombinant protein in transgenic fish |
| 01/31/2002 | US20020013952 Self-contained system for sustained viral replication |
| 01/31/2002 | US20020013456 Cortistatin: neuropeptides, compositions and methods |
| 01/31/2002 | US20020013452 Nucleotide sequences coding cytokine; for use in cancer treatment |
| 01/31/2002 | US20020013269 Human insulin analogues |
| 01/31/2002 | US20020013264 Glycosylaminoglycan (GAG) chains chemically modified with a carbodiimide such as 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide |
| 01/31/2002 | US20020013263 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| 01/31/2002 | US20020013258 Novel stem cell factor formulations and methods |
| 01/31/2002 | US20020012997 Transducing cell; incubate cells with nucleotide sequences, insert cells into mammals, monitor mammals for phenotypic adjustment |
| 01/31/2002 | US20020012995 Negative-sense RNA virus vector for nerve cell |
| 01/31/2002 | US20020012992 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor |
| 01/31/2002 | US20020012989 Genetically engineered nucleotide sequences coding preferential proteins for use in treatment of viral disease |
| 01/31/2002 | US20020012985 Microorganism culture; for use in food processsing |
| 01/31/2002 | US20020012981 Plant protein; for use in the development of disease rsistance plants |
| 01/31/2002 | US20020012968 Nucleotide sequence coding preferential proteins: for use in veterinary medicine and the treatment of tumor necrosis factor defects |
| 01/31/2002 | US20020012967 Insulin homolog polypeptide zins4 |
| 01/31/2002 | US20020012966 18 Human secreted proteins |
| 01/31/2002 | US20020012965 Nucleotide sequences coding prfeerential polypeptides for use in the diagnosis and treatment of brain disorders and injury |
| 01/31/2002 | US20020012964 Polypeptide for use in the diagnosis and treatment of cancer |
| 01/31/2002 | US20020012963 Nucleotide sequences coding preferential peptides; for use in diagnosing and treatment of allergies |
| 01/31/2002 | US20020012962 Nucleotide sequences coding fusion protein for use in the treatment of osteoporosis, cancers, and cachexia |
| 01/31/2002 | US20020012961 Nucleotide sequences coding preferential polypeptide; for use in diagnosis and treatment of cancers |
| 01/31/2002 | US20020012958 Increasing the fvii sensitivity of a thromboplastin reagent |
| 01/31/2002 | US20020012954 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth |
| 01/31/2002 | US20020012950 Screening for tumor metastasis; monitor sample for tumor marker protein expression, compare to control, evaluate tumor metastasis |
| 01/31/2002 | US20020012942 Polypeptides; for use in the diagnosis and treatment of cancer; antitumor agents; anticarcinogenic agents |
| 01/31/2002 | US20020012919 Nucleic acids of rochalimaea henselae and methods and compositions for diagnosing rochalimaea henselae and rochalimaea quintana infection |
| 01/31/2002 | US20020012670 Vaccines, therapy, prophylaxis |
| 01/31/2002 | US20020012669 For detecting a genetic abnormality, cancer |
| 01/31/2002 | US20020012668 Used in diagnostics, detection of the bacteria Salmonella.typhi or in the production of vaccines for typhoid fever |
| 01/31/2002 | US20020012661 Methods for introducing genes into mammalian subjects |
| 01/31/2002 | US20020012658 Prevention and treatment of verotoxin-induced disease |
| 01/31/2002 | US20020012656 Adenoviral vectors for mutants of human interleukin 6 (hil-6) with hil-6 antagonist activity, pharmaceutical compositions therewith and their uses |
| 01/31/2002 | DE10035867A1 Neue Nucleus-Export-Signalpeptide (NES), sie enthaltende Fusionsproteine sowie deren Verwendung New nucleus export signal peptides (NES), containing her fusion proteins and their use |
| 01/31/2002 | DE10032402A1 New peptide variants of the MUC1 tumor marker, useful for antitumor immunization and preparation of diagnostic antibodies |
| 01/31/2002 | CA2797652A1 Multi-component biological transport systems |
| 01/31/2002 | CA2427824A1 Human cytokine receptor |
| 01/31/2002 | CA2418333A1 Bicistronic influenza comprising two genes in tandem |
| 01/31/2002 | CA2418282A1 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/31/2002 | CA2418215A1 Novel fibroblast growth factor (fgf23) and methods for use |
| 01/31/2002 | CA2418199A1 Peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 01/31/2002 | CA2418198A1 Novel protein containing ring finger domaine r1p4 |
| 01/31/2002 | CA2417508A1 Glycosylated vegf-b and method for increasing the amount of soluble vegf-b |
| 01/31/2002 | CA2417223A1 A novel member of the epha receptor family |
| 01/31/2002 | CA2417134A1 Ho-1 suppressor as a diagnostic and prognostic test for dementing diseases |
| 01/31/2002 | CA2417010A1 Controlled environment agriculture bioreactor for heterologous protein production |
| 01/31/2002 | CA2416988A1 Leucine-based motif and clostridial neurotoxins |
| 01/31/2002 | CA2416761A1 Method for screening peptides for use in immunotherapy |
| 01/31/2002 | CA2416733A1 Nk cells activating receptors and their therapeutic and diagnostic uses |
| 01/31/2002 | CA2416713A1 Novel siglecs and uses thereof |
| 01/31/2002 | CA2416691A1 Proteases |
| 01/31/2002 | CA2416683A1 Dog melanin-concentrating hormone receptor |
| 01/31/2002 | CA2416676A1 Nucleic acids comprising regions of the rat peg-3 promoter and uses thereof |
| 01/31/2002 | CA2416664A1 Zinc finger domain recognition code and uses thereof |
| 01/31/2002 | CA2416657A1 Fh-binding protein of streptococcus pneumoniae |
| 01/31/2002 | CA2416643A1 Ghrelin antagonists |
| 01/31/2002 | CA2416548A1 Artificial vascular grafts, and methods of producing and using same |
| 01/31/2002 | CA2416544A1 Mu-conopeptides |
| 01/31/2002 | CA2416538A1 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 01/31/2002 | CA2416496A1 Adhesion molecules |
| 01/31/2002 | CA2416488A1 Codon-optimized papilloma virus sequences |
| 01/31/2002 | CA2416472A1 Nucleic acids compositions conferring dwarfing phenotype |
| 01/31/2002 | CA2416456A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/31/2002 | CA2416381A1 Gene-targeted non-human mammal with human fad presenilin mutation and generational offspring |
| 01/31/2002 | CA2416287A1 Omega-conopeptides |
| 01/31/2002 | CA2415586A1 Helicobacter pylori with modified lipopolysaccharide biosynthesis |
| 01/31/2002 | CA2415077A1 Cell cycle proteins and mitosis-associated molecules |
| 01/31/2002 | CA2413851A1 Modified virus having an altered tropism |
| 01/31/2002 | CA2412787A1 Process for the preparation of 5-phenylpentanoyl-ala-argl-{2-[3-amino-2-oxopyrrolidin-1-yl]propionyl}-ala-arg-ala-4-aminophenylacetamide |
| 01/31/2002 | CA2412626A1 Il-17 molecules and uses thereof |
| 01/31/2002 | CA2412544A1 Polypeptide delivery ii-2 |
| 01/31/2002 | CA2412408A1 Human tumor necrosis factor receptors tr21 and tr22 |
| 01/31/2002 | CA2385371A1 Method of purifying calcium ion-binding protein |
| 01/30/2002 | EP1176215A2 Amplification and detection of mycoplasma pneumoniae |
| 01/30/2002 | EP1176206A2 Barley DEAD box protein HVD1 gene induced by salt stress |
| 01/30/2002 | EP1176201A2 Platelet-specific chimeric immunoglobulin |
| 01/30/2002 | EP1176199A1 Tumor suppressor genes |
| 01/30/2002 | EP1176198A1 Novel fetal genes |
| 01/30/2002 | EP1176197A1 A transgenic animal model for cardiac arrhythmias |
| 01/30/2002 | EP1176193A1 Inhibitors for viral infection targeting integrase n-terminal region |
| 01/30/2002 | EP1176192A2 Helicobacter felis vaccine |
| 01/30/2002 | EP1176152A2 Ligand binding domain of ultraspiracle protein (usp) |
| 01/30/2002 | EP1176134A1 Ligands of nuclear receptors ppar's |
| 01/30/2002 | EP1175911A2 Uses of recombinant colony stimulating factor-1 for treatment of leukopenia |
| 01/30/2002 | EP1175910A2 Methods and compounds for prevention of graft rejection |
| 01/30/2002 | EP1175909A2 Therapeutic methods and compositions based on serrate proteins and nucleic acids |
| 01/30/2002 | EP1175839A2 Antimicrobial agent against acid-resistant and heat-resistant bacteria |
| 01/30/2002 | EP1175616A1 Methods for the diagnosis and treatment of metastatic prostate tumors |
| 01/30/2002 | EP1175513A1 MinK-RELATED GENES, FORMATION OF POTASSIUM CHANNELS AND ASSOCIATION WITH CARDIAC ARRHYTHMIA |
| 01/30/2002 | EP1175508A1 Optical probes and assays |
| 01/30/2002 | EP1175506A2 Compound screening method |
| 01/30/2002 | EP1175504A1 Dna encoding the human vanilloid receptor vr1 |
| 01/30/2002 | EP1175503A1 49 human secreted proteins |
| 01/30/2002 | EP1175497A2 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
| 01/30/2002 | EP1175496A1 RECOMBINANT i PENICILLIUM FUNICULOSUM /i FOR HOMOLOGOUS AND HETEROLOGOUS PROTEIN PRODUCTION |
| 01/30/2002 | EP1175492A1 Star homologues |
| 01/30/2002 | EP1175491A1 Recombinant protein uk114 and its use in therapy and diagnostics |
| 01/30/2002 | EP1175490A2 Tyrosine kinase substrate (tks) proteins |
| 01/30/2002 | EP1175444A1 Amino-terminal modified parathyroid hormone (pth) analogs |